About us

Our origin, our commitment

Vivotecnia had its origin in the year 2000 in Madrid with a clear mission: to offer top-level preclinical research services with scientific rigor, ethical commitment and personalized attention to each client. 

Preclinical regulatory CRO

Scroll down

Established – 2000

More than 25 years of evolution

Since our origin, we have grown from a local CRO into a global benchmark in non-clinical toxicology studies. Our trajectory is built on innovation, transparency, and a team deeply committed to science

Infrastructure and equipment

Vivotecnia milestones

Key milestones in our history

  1. Origin of Vivotecnia

    2000

    Foundation of Vivotecnia in Madrid as a laboratory for toxicology and preclinical in vivo safety testing.

  2. GLP Certification in Toxicology

    2003

    Obtaining GLP certification in toxicology for chemical and pharmaceutical products.

  3. New species

    2005

    Incorporation of minipigs and nonhuman primates (NHPs) as new species for testing.

  4. Expansion of inhalation

    2007

    Expansion of inhalation facilities, increasing capacity and specific equipment by 30%.

  5. Consolidation as an independent CRO

    2010

    Vivotecnia consolidates its position as an independent European CROspecializing in toxicology and pharmacological safety. Integration of a quality system aligned with ISO 9001 and GLP.

  6. Expansion und internationale Ausrichtung

    2015

    Strengthening our position as a leading CRO for the pharmaceutical, biotech, chemical, agrochemical, and cosmetics industries. Greater presence in national and international networks and conferences.

  7. Global expansion of facilities

    2021

    Doubling the surface area of the facilities, expanding laboratories, animal facilities, and offices.

  8. Bioanalysis unit

    2022

    Implementation of the GLP bioanalysis unit for bioanalytical methods and support for TK/biomarkers.

  9. Current situation

    2025

    More than 4,500 studies conducted, focusing on preclinical in vivo development. Vivotecnia consolidates its position as a strategic partner for the regulatory advancement of new drugs, biologics, and innovative products.

We are proud of where we come from – and even more excited about where we’re going.

If you are looking for a committed team,
with experience and scientific vision,
Vivotecnia is your ally in preclinical
toxicology.

We use cookies

We use cookies to improve your experience on this website. You may choose which types of cookies to allow and change your preferences at any time. Disabling cookies may impact your experience on this website. You can learn more by viewing our Cookie Policy.